Science Explorer Back to mapMap
Discussion

NewGen Therapeutics (United States)

Research works
84
▲ 271% vs 2018-21
Citations
2.9k
34.9 per fractional work
Top-10% rate
14.8%
all institutions 10.0%
Open access
48%
world 40%
International
27%
world 18%
NewGen Therapeutics (United States)

Not ranked overall: NewGen Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does NewGen Therapeutics (United States) work in?

In 2022-now, 59% of research at NewGen Therapeutics (United States) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (58%), Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (5%). It does 2.2× the world's share of Life Sciences.

Health Sciences: 20 fractional works · 58.9% of its workMedicine: 20 fractional works · 58.5% of its workOncology: 6 fractional works · 19.0% of its workEpidemiology: 3 fractional works · 8.9% of its workPulmonary and Respiratory Medicine: 3 fractional works · 8.1% of its workInfectious Diseases: 2 fractional works · 5.2% of its workSurgery: 1 fractional works · 2.6% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.3% of its workRheumatology: 1 fractional works · 2.0% of its workGenetics: 1 fractional works · 1.9% of its workNeurology: 1 fractional works · 1.6% of its workOphthalmology: 0 fractional works · 1.2% of its workHematology: 0 fractional works · 1.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 1.0% of its workComplementary and alternative medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.5% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.1% of its workLife Sciences: 13 fractional works · 39.1% of its workBiochemistry, Genetics and Molecular Biology: 11 fractional works · 32.6% of its workMolecular Biology: 7 fractional works · 21.9% of its workGenetics: 1 fractional works · 4.2% of its workCell Biology: 1 fractional works · 3.2% of its workCancer Research: 1 fractional works · 2.2% of its workBiotechnology: 0 fractional works · 1.0% of its workImmunology and Microbiology: 2 fractional works · 4.7% of its workImmunology: 2 fractional works · 4.7% of its workNeuroscience: 0 fractional works · 1.4% of its workNeurology: 0 fractional works · 0.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 1 fractional works · 1.8% of its workChemistry: 0 fractional works · 0.8% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.4% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKNewGenTherapeutics…34fractional works, 2022-now
Life Sciences39%Physical Sciences2%Health Sciences59%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine2058.5%
    2. Veterinary00.3%
    3. Health Professions00.1%
    1. Biochemistry, Genetics and Molecular Biology1132.6%
    2. Immunology and Microbiology24.7%
    3. Neuroscience01.4%
    4. Agricultural and Biological Sciences00.4%
    1. Chemistry00.8%
    2. Engineering00.4%
    3. Materials Science00.2%
    4. Energy00.1%
    5. Environmental Science00.1%
    1. Business, Management and Accounting00.1%
    2. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.11× its world share, 11 worksBiochemistry, Geneti…Immunology and Microbiology: 4.67× its world share, 2 worksImmunology and Micro…Neuroscience: 0.85× its world share, 0 worksNeuroscienceChemistry: 0.53× its world share, 0 worksChemistryEnergy: 0.15× its world share, 0 worksEnergyEngineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.06× its world share, 0 worksMaterials ScienceHealth Professions: 0.04× its world share, 0 worksHealth ProfessionsMedicine: 3.04× its world share, 20 worksMedicineVeterinary: 2.40× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.04× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.06× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.1×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology6.11×11 works
  2. Immunology and Microbiology4.67×2 works
  3. Medicine3.04×20 works
  4. Veterinary2.40×0 works
  5. Neuroscience0.85×0 works
  6. Chemistry0.53×0 works
  7. Energy0.15×0 works
  8. Agricultural and Biological Sciences0.09×0 works
  9. Materials Science0.06×0 works
  10. Economics, Econometrics and Finance0.06×0 works
  11. Health Professions0.04×0 works
  12. Business, Management and Accounting0.04×0 works
  13. Engineering0.03×0 works
  14. Environmental Science0.03×0 works

What are the most cited papers from NewGen Therapeutics (United States)?

The most cited paper from NewGen Therapeutics (United States) is "A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)" (Caroline M. Apovian, Louis J. Aronne, Domenica Rubino et al., 2013), with 722 citations. Next come "Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer" (500) and "Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials" (387).

Most cited papers
#PaperReleasedCitations
1 A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) Caroline M. Apovian, Louis J. Aronne, Domenica Rubino et al. · Obesity Open access 14 Feb 2013 722
2 Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer Stephen G. Swisher et al. · JNCI Journal of the National Cancer Institute 5 May 1999 500
3 Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials Donghua Shi, Yao Shi, Ahmed Omar Kaseb et al. · Clinical Cancer Research 5 May 2020 387
4 The Protein Product of the Tumor Suppressor Gene, Melanoma Differentiation-Associated Gene 7, Exhibits Immunostimulatory Activity and Is Designated IL-24 Eva G. Caudell, John Brian Mumm, Nancy J Poindexter et al. · The Journal of Immunology Jun 2002 262
5 Genetically engineered T cells for cancer immunotherapy Dan Li, Xue Li, Weilin Zhou et al. · Signal Transduction and Targeted Therapy Open access 19 Sep 2019 249
All 60 most cited papers, with filters and sorting

Which keywords describe research at NewGen Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Treatment, Diagnosis, Immunotherapy, Epidemiology, Cancer Immunotherapy, Tumor Regression, Antibiotic Resistance and CAR T Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Epidemiology5▲ 3.6×11 topics
  2. Diagnosis4▲ 14×5 topics
  3. Treatment4▲ 10×6 topics
  4. Immunotherapy4▲ 15×9 topics
  5. Cancer Immunotherapy3▲ 59×3 topics
  6. Tumor Regression3▲ 70×2 topics
  7. Antibiotic Resistance2▲ 18×2 topics
  8. CAR T Cells2▲ 93×1 topic
  9. Chimeric Antigen Receptor2▲ 93×1 topic
  10. Mycobacterium avium2▲ 208×1 topic
  11. Nontuberculous Mycobacteria2▲ 208×1 topic
  12. Cancer2▲ 4.6×12 topics
  13. Immune Response2▲ 11×8 topics
  14. Chemotherapy2▲ 8.5×7 topics
  15. Cancer Therapy2▲ 9.9×8 topics
  16. Gene Therapy2▲ 29×5 topics
  17. Drug Resistance2▲ 18×3 topics
  18. Vaccine2▲ 12×4 topics
  19. Angiogenesis2▲ 14×4 topics
  20. Breast Cancer2▲ 19×4 topics
  21. Genetic Diversity2▲ 10×2 topics
  22. Inflammation2▲ 2.2×9 topics
  23. Mycobacterium tuberculosis2▲ 79×1 topic
  24. Tuberculosis2▲ 83×1 topic
  25. Innate Immunity1▲ 12×4 topics
  26. Cell Signaling1▲ 25×3 topics
  27. Targeted Therapy1▲ 18×4 topics
  28. Toll-like Receptors1▲ 30×3 topics
  29. Tumor Microenvironment1▲ 7.6×4 topics
  30. Genomic Integration1▲ 57×2 topics
  31. Glycosylation1▲ 29×2 topics

Which research topics does NewGen Therapeutics (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Mycobacterium research and diagnosis, Tuberculosis Research and Epidemiology and CRISPR and Genetic Engineering.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Mycobacterium research and diagnosis Epidemiology 2 works
  3. 3 Tuberculosis Research and Epidemiology Infectious Diseases 2 works
  4. 4 CRISPR and Genetic Engineering Molecular Biology 1 works
  5. 5 Virus-based gene therapy research Genetics 1 works
  6. 6 Proteoglycans and glycosaminoglycans research Cell Biology 1 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 1 works
  9. 9 Immunotherapy and Immune Responses Immunology 1 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.5%not open52.5%

World: 40% of research is openly available.

with international co-authors26.9%domestic only73.1%

World: 18% is written across borders.

How has NewGen Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 271% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is NewGen Therapeutics (United States) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.00020%0.00040%0.00060%NewGen Therapeutics (United States)0.00016% in 202519801990200020102020

Fractional works of NewGen Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Menlo Park

All research institutions in Menlo Park

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about NewGen Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.